Physician profile
Jonathan D Leff
NPI 1881779270
$15,919.56
in general payments reported to CMS, 2019-2025
10 companies · $4,302 in 2025
The $4,302 reported for 2025 was more than what 98% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,877 · 2020: $4,235 · 2021: $19.79 · 2022: $332 · 2023: $556 · 2024: $597 · 2025: $4,302.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,110 · Honoraria: $2,000 · Travel and Lodging: $1,345.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,110.47 |
| Honoraria | $2,000.00 |
| Travel and Lodging | $1,344.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Octapharma USA, INC. | $7,164.27 | 2020-2025 | Fibryga & Balfaxar, Panzyga |
| Edwards Lifesciences Corporation | $6,044.75 | 2019-2023 | Hemosphere |
| Becton, Dickinson and Company | $845.44 | 2024-2025 | |
| Abiomed | $737.49 | 2023-2025 | Impella |
| Cas Medical Systems INC. | $691.57 | 2019 | |
| Biosense Webster, INC. | $241.62 | 2022-2024 | Octaray Mapping Catheter, Nuvision Ice Catheter |
| Boston Scientific Corporation | $102.42 | 2022-2025 | Farapulse, Versacross Access Solution |
| Cumberland Pharmaceuticals, INC. | $39.46 | 2019 | |
| Abbott Laboratories | $32.75 | 2023 | 2nd Gen Centrimag Primary Console |
| Mindray Ds USA, INC. | $19.79 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Leff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.